Nancy Brown

Dean

Yale University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Nancy Brown is the Dean at Yale University, United States. Her research areas include adipose tissue function, obesity, medication adherence, and cardiovascular health. Recent articles authored by her focus on therapeutic approaches for obesity and hypertension, as well as the role of dipeptidyl peptidase-4 in cardiovascular treatments.

Articles (9)

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Jane Reckelhoff

Professor and Chair

University of Mississippi Medical Center

UNITED STATES

View details

Wanpen Vongpatanasin

MD, Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Ann Marie Schmidt

New York University Grossman School of Medicine

UNITED STATES

View details

Ashley N. Battarbee

The University of Alabama

UNITED STATES

View details

Sandeep Das

Associate Professor

University of Texas Southwestern Medical School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nancy Brown

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Regional and systemic adipose mass and peripheral conduit artery function

Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network

Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting

DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment

Connecting Generations of Scientists in the Council on Hypertension Through Harriet Dustan

Active B-Type Natriuretic Peptide Measured by Mass Spectrometry and Response to Sacubitril/Valsartan

Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program

Skeletal Muscle Mitochondrial Dysfunction Is Present in Patients with CKD before Initiation of Maintenance Hemodialysis

Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”

Collaborators (5)

Jane Reckelhoff

Wanpen Vongpatanasin

Ann Marie Schmidt

Ashley N. Battarbee

Sandeep Das

Make your next move.